Detail of the clinical trial
| Title of the trial | Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects |
|---|---|
| EudraCT number | 2020-004027-17 |
| Protocol number | SGN35-027 |
| Sponsor | Seagen Inc., 21823 30th Drive SE, Bothell, WA 98021, United states of America |
| Indications | Hemato-oncology |
| Diagnosis | Hodgkin Lymphoma |
| Population in clinical trial |
Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2021 |
| Date of approval by Institute (SÚKL) | 19. 8. 2021 |
| Date of approval by EC | 23. 9. 2021 |
| Date of initiation CT in ČR | 5.4.2022 |
| Date of ending CT in ČR | |
| Notice | |
| Sites |
Fakultní nemocnice Brno,Interní hematoonkologická klinika,Jihlavská 20,Brno,625 00 Všeobecná fakultní nemocnice,I.interní klinika, U nemocnice 2,Praha 2,128 08 Fakultní nemocnice Královské Vinohrady,Hematologická klinika,Šrobárova 1150/50,Praha 10,100 34 Fakultní nemocnice Hradec Králové, IV. interní klinika,Sokolská 581,Hradec Králové, 500 05 |
cz